SNNA

Sienna Biopharmaceuticals, Inc.
SNNA

Delisted

SNNA was delisted on the 16th of December, 2019.

Back to rankings

34 hedge funds and large institutions have $178M invested in Sienna Biopharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$66.2M
2
+$35.2M
3
+$16.9M
4
CCP
Clough Capital Partners
Massachusetts
+$16.4M
5
Victory Capital Management
Victory Capital Management
Texas
+$10.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$66.3M
2
$35.2M
3
$16.9M
4
$16.4M
5
$10.2M
6
$8.57M
7
$6.7M
8
$4.99M
9
$2.87M
10
$1.37M
11
$1.13M
12
$1.11M
13
$926K
14
$890K
15
$882K
16
$586K
17
$556K
18
$471K
19
$440K
20
$274K
21
$193K
22
$183K
23
$182K
24
$162K
25
$104K
1
2